Physician profile

Amara Lai

Family Medicine · National City, CA

NPI 1790912855

$262.93

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$103.07

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $69.35 2021-2023 Wegovy
Organon LLC $36.40 2022
Cranial Technologies, INC $31.00 2022-2023 Doc Band
Daiichi Sankyo INC. $24.67 2023 Injectafer
Sanofi Pasteur INC. $24.23 2021
Exact Sciences Corporation $23.77 2023 Cologuard Collection Kit
Coopersurgical, INC. $19.23 2024 Paragard T 380a
Abbvie INC. $18.04 2022
Merck Sharp & Dohme LLC $16.24 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Amara Lai

$262.93

in general payments reported 2019-2025

Years
2019-2024
Top company
Novo Nordisk INC

https://glasscript.com/doctor/670864/amara-lai

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.